Cantel Medical (NYSE: CMD) reported Q2 EPS of $0.71, $0.14 better than the analyst estimate of $0.57. Revenue for the quarter came in at $213 million versus the consensus estimate of $211.44 million.

For earnings history and earnings-related data on Cantel Medical (CMD) click here.